stoxline Quote Chart Rank Option Currency Glossary
  
(RZB)
  0 (0%)    09-27 11:12
Open:
High:
Volume: 0
  
Pre. Close:
Low:
Market Cap: 0(M)
Technical analysis
2025-09-26 4:51:09 PM
Short term     
Mid term     
Targets 6-month :  29.37 1-year :  34.31
Resists First :  25.14 Second :  29.37
Pivot price 24.93
Supports First :  24.85 Second :  24.67
MAs MA(5) :  24.9 MA(20) :  24.89
MA(100) :  24.83 MA(250) :  24.82
MACD MACD :  0 Signal :  0
%K %D K(14,3) :  49.3 D(3) :  53.6
RSI RSI(14): 52.4
52-week High :  26 Low :  24.11
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ RZB ] has closed below upper band by 46.5%. Bollinger Bands are 45.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 24.96 - 25.09 25.09 - 25.21
Low: 24.56 - 24.7 24.7 - 24.83
Close: 24.73 - 24.94 24.94 - 25.14
Company Description

Headline News

Fri, 08 Aug 2025
Here, we report the e󰀩cacy and safety results from the KEEPsAKE 2 trial through week 196 - researchgate.net

Fri, 20 Jun 2025
Reinsurance Group Baby Bonds Offer A High Yield To Likely Call (NYSE:RGA) - Seeking Alpha

Thu, 03 Apr 2025
JP Morgan Upgrades Reinsurance Group of America, Incorporated - Preferred Stock (RZB) - Nasdaq

Thu, 27 Mar 2025
Risankizumab improves long-term outcomes in patients with palmoplantar pustulosis: Study - Medical Dialogues

Wed, 19 Feb 2025
Reinsurance Group: Baby Bonds Offer A Solid Return In Either Outcome - Seeking Alpha

Mon, 03 Feb 2025
Extended Risankizumab Treatment in Patients With Crohn’s Disease Who Did Not Achieve Clinical Response to Induction Treatment - ScienceDirect.com

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Neutral
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
Sector:
Industry:
Shares Out 63 (M)
Shares Float 66 (M)
Held by Insiders 0 (%)
Held by Institutions 0 (%)
Shares Short 0 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS 6.09
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 182.36
Profit Margin 3.5 %
Operating Margin 7.6 %
Return on Assets (ttm) 0.7 %
Return on Equity (ttm) 7 %
Qtrly Rev. Growth 14.8 %
Gross Profit (p.s.) 44.44
Sales Per Share 346.5
EBITDA (p.s.) 24.37
Qtrly Earnings Growth -10.9 %
Operating Cash Flow 4,920 (M)
Levered Free Cash Flow 1,990 (M)
Stock Valuations
PE Ratio 4.09
PEG Ratio 0
Price to Book value 0.13
Price to Sales 0.07
Price to Cash Flow 0.31
Stock Dividends
Dividend 0.36
Forward Dividend 0
Dividend Yield 1.4%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android